Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SUGP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR132 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANAPC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEKR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD51C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UACA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT5-GP1BB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724870 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIF4GD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM63A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on